Literature DB >> 30059753

Association of IL18 genetic polymorphisms with increased risk of Biliary atresia susceptibility in Southern Chinese children.

Jiankun Liang1, Zhe Wen1, Jinglu Zhao1, Qifeng Liang1, Tao Liu1, Huimin Xia1, Yan Zhang2, RuiZhong Zhang3.   

Abstract

Biliary atresia (BA) has complex genetic etiology, characterized by different levels of hepatic fibrosis after the Kasai procedure and immune responses to the bile duct. As an activator of the two most important inflammatory cells in Biliary atresia (T cells and NK cells), IL-18 is significantly increased in BA patients. This study aims to investigate the association of Interleukin 18(IL-18) with the susceptibility to BA. We examined the association of three polymorphisms (rs549908, rs187238 and rs1946518 in IL-18) and BA susceptibility in a Southern Chinese population composed of 506 cases and 1473 controls. SNP rs187238 and rs1946518 were identified as associated with BA. Interestingly, we also observed that the intragenic synergistic epistasis between SNPs rs187238 and rs1946518 boosting the risk to BA by logistic regression and Multifactor dimensionality reduction (MDR) analysis. This study provides for the first time a direct evidence to support IL-18 as a susceptibility gene for the disease in southern Chinese children.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Association; Biliary atresia; Genetic polymorphisms; IL18

Mesh:

Substances:

Year:  2018        PMID: 30059753     DOI: 10.1016/j.gene.2018.07.071

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

Review 1.  Genetic Factors and Their Role in the Pathogenesis of Biliary Atresia.

Authors:  Li-Na Wu; Zhi-Jun Zhu; Li-Ying Sun
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

2.  Irrelevance of USF2 rs916145 polymorphism with the risk of biliary atresia susceptibility in Southern Chinese children.

Authors:  Lei Chen; Ming Fu; Ledong Tan; Jinglu Zhao; Xiaogang Xu; Yuzhen Lin; Qian Zhong; Ruisui Zhong; RuiZhong Zhang; Jixiao Zeng
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.